Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | ALLO-501A |
Trade Name | |
Synonyms | ALLO 501A|ALLO501A|Allogeneic Anti-CD19 CAR T-cells ALLO-501A |
Drug Descriptions |
ALLO-501A are allogenic CD52 negative T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD19, a tumor cell surface protein, which potentially results in tumor cell lysis via binding to CD19-expressing tumor cells (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C172708 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ALLO-501A | ALLO-501A | 0 | 2 |